A webinar sponsored by Medable will explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
Chimerix is selling global rights to smallpox drug Tembexa, the biotech’s only FDA-approved product, as a way to fund clinical development of a therapy in pivotal testing for a rare type of brain cancer. The deal marks Chimerix’s nearly complete departure from the...
Covid changed things for medical affairs teams at pharmaceutical companies, causing was a fundamental shift in the way they worked and functioned. The role of the medical science liaison—a key member of the medical affairs team—has also evolved.
An analytics-driven A/R strategy can significantly improve collections in today’s healthcare environment. This article goes over the pillars of this approach as well as what metrics should be focused on in implementing such a strategy.
The Boston-based company announced Monday that it had received 510(k) clearance from the FDA for its Caries Assist, software that uses AI to aid dentists in detecting cavities. In May last year, Overjet received FDA clearance for AI-powered technology used in the...
Research and innovation in machine learning in the pharmaceutical sector is on the rise. The most recent figures show that the number of related patent applications in the industry stood at 77 in the three months ending March – up from 66 over the same period in...
